Ligand Pharmaceuticals, Inc. (LGND)
247.90
+4.62
(+1.90%)
USD |
NASDAQ |
Jun 10, 16:00
247.82
-0.08
(-0.03%)
After-Hours: 18:00
Ligand Pharmaceuticals EPS Diluted (TTM) : 7.376 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | 7.376 |
| December 31, 2025 | 5.835 |
| September 30, 2025 | 2.078 |
| June 30, 2025 | -3.997 |
| March 31, 2025 | -7.119 |
| December 31, 2024 | -0.154 |
| September 30, 2024 | 2.513 |
| June 30, 2024 | 2.312 |
| March 31, 2024 | 5.320 |
| December 31, 2023 | 2.901 |
| September 30, 2023 | 0.8368 |
| June 30, 2023 | 1.452 |
| March 31, 2023 | 1.269 |
| December 31, 2022 | -1.979 |
| September 30, 2022 | -1.268 |
| June 30, 2022 | -0.4907 |
| March 31, 2022 | 1.352 |
| December 31, 2021 | 3.316 |
| September 30, 2021 | 3.985 |
| June 30, 2021 | 2.768 |
| March 31, 2021 | 2.301 |
| December 31, 2020 | -0.2083 |
| September 30, 2020 | -0.9807 |
| June 30, 2020 | -1.376 |
| March 31, 2020 | -3.437 |
| Date | Value |
|---|---|
| December 31, 2019 | 29.34 |
| September 30, 2019 | 27.75 |
| June 30, 2019 | 31.36 |
| March 31, 2019 | 35.09 |
| December 31, 2018 | 5.604 |
| September 30, 2018 | 7.288 |
| June 30, 2018 | 4.846 |
| March 31, 2018 | 2.116 |
| December 31, 2017 | 0.5063 |
| September 30, 2017 | 0.6888 |
| June 30, 2017 | 0.3767 |
| March 31, 2017 | -0.1795 |
| December 31, 2016 | -0.1364 |
| September 30, 2016 | 0.3032 |
| June 30, 2016 | 9.538 |
| March 31, 2016 | 10.94 |
| December 31, 2015 | 10.72 |
| September 30, 2015 | 10.77 |
| June 30, 2015 | 1.55 |
| March 31, 2015 | 0.51 |
| December 31, 2014 | 0.57 |
| September 30, 2014 | 0.32 |
| June 30, 2014 | 0.35 |
| March 31, 2014 | 0.4608 |
| December 31, 2013 | 0.4251 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Organon & Co. | 0.9387 |
| Johnson & Johnson | 8.649 |
| Merck & Co., Inc. | 3.553 |
| ANI Pharmaceuticals, Inc. | 3.942 |
| Corcept Therapeutics, Inc. | 0.35 |